Phenomic technologies in drug discovery of neglected diseases
2011

Using Phenomic Technologies to Discover New Drugs for Neglected Diseases

Sample size: 200000 publication Evidence: moderate

Author Information

Author(s): Nehrbass Ulf, Roberto Bruzzone

Primary Institution: Institut Pasteur-Korea

Hypothesis

Can phenomic technologies help in discovering new treatments for neglected diseases like Leishmaniasis, Chagas Disease, and Dengue?

Conclusion

The study successfully screened hundreds of thousands of compounds to find potential new drugs for neglected diseases.

Supporting Evidence

  • Leishmaniasis, Chagas Disease, and Dengue are neglected diseases with high mortality rates.
  • 200,000 drugs were screened for their effectiveness against Leishmaniasis.
  • 150,000 compounds were screened for their ability to inhibit Trypanosoma cruzi in Chagas disease.
  • High-throughput screening assays were developed for malaria targeting P. falciparum.

Takeaway

Scientists are using special technology to find new medicines for diseases that don't have good treatments right now.

Methodology

High-content/high-throughput screening assays were developed to test large numbers of compounds against pathogens inside human cells.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication